Ezetimibe, a cholesterol absorption inhibitor that targets uptake at the jejunal enterocyte brush border, can be used alternatively or in combination with statins, while PCSK9 inhibitors such as Evolocumab and Alirocumab, are indicated in familiar hypercholesterolemia (Table 1). The gene discussed is PCSK9; the disease is Hypercholesterolemia.